GLSI

Greenwich LifeSciences, Inc.

23.36

USD

GLSI Earnings Reports

Positive Surprise Ratio

GLSI beat 11 of 18 last estimates.

61%

Next Report

Date of Next Report

Apr 13, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.32

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-47.54%

Greenwich LifeSciences, Inc. earnings per share and revenue

On --, GLSI reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.32 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Precigen, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.01

Surprise

+88.24%

Candel Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.54

Surprise

-115.31%

Acumen Pharmaceuticals, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.46

Actual

-$0.41

Surprise

+11.29%

Spero Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.20

Actual

$0.53

Surprise

+359.80%

Rani Therapeutics Holdings, Inc. Class A Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.07

Surprise

-2.94%

Alpha Cognition Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.30

Surprise

-8.93%

Equillium, Inc. Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.04

Surprise

+35.28%

Cognition Therapeutics, Inc. Common Stock

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.02

Surprise

+76.47%

Quantum Biopharma Ltd. Class B Subordinate Voting Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

Actual

-$0.71

Surprise

CollPlant Biotechnologies Ltd Ordinary Shares

Report Date

Mar 26, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.67

Surprise

-245.72%

FAQ

What were Greenwich LifeSciences, Inc.'s earnings and revenue for the latest quarter Q-- --?

For Q-- --, Greenwich LifeSciences, Inc. reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to Greenwich LifeSciences, Inc.'s Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Greenwich LifeSciences, Inc. expected to report next?

The next earning report is scheduled for Apr 13, 2026.

What are the forecasts for Greenwich LifeSciences, Inc.'s next earnings report?

Based on 3 analysts, Greenwich LifeSciences, Inc. is expected to report EPS of -$0.32 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.